A Toxoplasma gondii-derived ROP38 protein engages Ser15/Thr18-linked p53 activation and DNA damage-associated apoptotic signaling in human cancer cells.
Seung-Hwan Seo, Ji-Eun Lee, Eun-Ji Cho, Eun-Hee Shin
{"title":"A Toxoplasma gondii-derived ROP38 protein engages Ser15/Thr18-linked p53 activation and DNA damage-associated apoptotic signaling in human cancer cells.","authors":"Seung-Hwan Seo, Ji-Eun Lee, Eun-Ji Cho, Eun-Hee Shin","doi":"10.1186/s12964-026-03257-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The tumor suppressor p53 integrates diverse cellular stresses to regulate DNA damage responses, cell-cycle progression, and apoptosis-associated signaling. Toxoplasma gondii secretes rhoptry effectors that remodel host signaling networks, but the host targets and signaling functions of the rhoptry kinase ROP38 remain poorly defined.</p><p><strong>Methods: </strong>GFP-tagged T. gondii ME49 ROP38 full-length protein (ROP38 Full) and its kinase-domain fragment (ROP38 KiD) were stably expressed in HCT116 and HepG2 human cancer cells. Kinase-associated activity was assessed in anti-GFP immunoprecipitates, and a candidate co-immunoprecipitation screen was used to identify ROP38-associated host proteins. ROP38-p53 association and phospho-p53 species were further examined by co-immunoprecipitation. Purified recombinant ROP38 and human p53 were used for direct interaction and in vitro phosphorylation assays. Whole-cell p53 signaling, DNA damage/apoptosis-associated markers, and cell-cycle distribution were also analyzed. Statistical analyses used one- or two-way ANOVA, as appropriate, followed by Tukey's multiple comparisons test.</p><p><strong>Results: </strong>ROP38 Full- and ROP38 KiD-containing immunoprecipitates showed increased kinase-associated activity. Among the candidate proteins examined, p53 was the only ROP38-associated host factor detected in both cell lines. ROP38 Full and ROP38 KiD co-immunoprecipitated with total p53 and preferentially enriched p53 phosphorylated at Ser15 and Thr18. Purified recombinant ROP38 directly associated with recombinant p53 and promoted Ser15/Thr18 phosphorylation in the presence of ATP. At the whole-cell level, ROP38 expression increased p53 abundance and multisite phosphorylation, with prominent Ser15/Thr18 induction, and was accompanied by increased γH2AX, PUMA, cleaved caspase-3, and p21 expression. ROP38-expressing cells also showed decreased G<sub>1</sub>-phase populations with increased S- and G<sub>2</sub>/M-phase populations.</p><p><strong>Conclusions: </strong>These data identify a candidate ROP38-associated p53 signaling module in human cancer cells and provide biochemical evidence that ROP38 can directly associate with p53 and promote Ser15/Thr18 phosphorylation in vitro. The requirement for intrinsic ROP38 catalytic activity and the physiological relevance of this relationship during T. gondii infection remain to be established.</p>","PeriodicalId":55268,"journal":{"name":"Cell Communication and Signaling","volume":"24 1","pages":""},"PeriodicalIF":11.6000,"publicationDate":"2026-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13670628/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell Communication and Signaling","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1186/s12964-026-03257-5","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The tumor suppressor p53 integrates diverse cellular stresses to regulate DNA damage responses, cell-cycle progression, and apoptosis-associated signaling. Toxoplasma gondii secretes rhoptry effectors that remodel host signaling networks, but the host targets and signaling functions of the rhoptry kinase ROP38 remain poorly defined.
Methods: GFP-tagged T. gondii ME49 ROP38 full-length protein (ROP38 Full) and its kinase-domain fragment (ROP38 KiD) were stably expressed in HCT116 and HepG2 human cancer cells. Kinase-associated activity was assessed in anti-GFP immunoprecipitates, and a candidate co-immunoprecipitation screen was used to identify ROP38-associated host proteins. ROP38-p53 association and phospho-p53 species were further examined by co-immunoprecipitation. Purified recombinant ROP38 and human p53 were used for direct interaction and in vitro phosphorylation assays. Whole-cell p53 signaling, DNA damage/apoptosis-associated markers, and cell-cycle distribution were also analyzed. Statistical analyses used one- or two-way ANOVA, as appropriate, followed by Tukey's multiple comparisons test.
Results: ROP38 Full- and ROP38 KiD-containing immunoprecipitates showed increased kinase-associated activity. Among the candidate proteins examined, p53 was the only ROP38-associated host factor detected in both cell lines. ROP38 Full and ROP38 KiD co-immunoprecipitated with total p53 and preferentially enriched p53 phosphorylated at Ser15 and Thr18. Purified recombinant ROP38 directly associated with recombinant p53 and promoted Ser15/Thr18 phosphorylation in the presence of ATP. At the whole-cell level, ROP38 expression increased p53 abundance and multisite phosphorylation, with prominent Ser15/Thr18 induction, and was accompanied by increased γH2AX, PUMA, cleaved caspase-3, and p21 expression. ROP38-expressing cells also showed decreased G1-phase populations with increased S- and G2/M-phase populations.
Conclusions: These data identify a candidate ROP38-associated p53 signaling module in human cancer cells and provide biochemical evidence that ROP38 can directly associate with p53 and promote Ser15/Thr18 phosphorylation in vitro. The requirement for intrinsic ROP38 catalytic activity and the physiological relevance of this relationship during T. gondii infection remain to be established.
期刊介绍:
Cell Communication and Signaling (CCS) is a peer-reviewed, open-access scientific journal that focuses on cellular signaling pathways in both normal and pathological conditions. It publishes original research, reviews, and commentaries, welcoming studies that utilize molecular, morphological, biochemical, structural, and cell biology approaches. CCS also encourages interdisciplinary work and innovative models, including in silico, in vitro, and in vivo approaches, to facilitate investigations of cell signaling pathways, networks, and behavior.
Starting from January 2019, CCS is proud to announce its affiliation with the International Cell Death Society. The journal now encourages submissions covering all aspects of cell death, including apoptotic and non-apoptotic mechanisms, cell death in model systems, autophagy, clearance of dying cells, and the immunological and pathological consequences of dying cells in the tissue microenvironment.